News Channels

11 Aug 2017 Biotecnol and CRUK to Trial New Immuno-Oncology Treatment for Advanced Solid Tumours
11 Aug 2017 Sutro & Celgene to Refocus 2014 Immuno-Oncology Collaboration on Four Programs
11 Aug 2017 AnaptysBio Announces Second Quarter 2017 Financial Results and Provides Pipeline Updates
10 Aug 2017 BioSight Completed Patient Enrollment and Treatment in its Extended Acute Leukemia Phase I/II Clinical Trial with BST-236, a Novel Cytarabine Pro-Drug
10 Aug 2017 Korea Institute of Science and Technology (KIST) Develops a New Drug for Alzheimer's Disease
10 Aug 2017 PharmaMar Starts a Quadruple Combination Study With AplidinĀ® for the Treatment of Multiple Myeloma
10 Aug 2017 CARsgen Launches First-in-Class Anti-Claudin18.2 CAR-T Clinical Trial
10 Aug 2017 GLPG1690 halts disease progression in IPF patients in FLORA Phase 2a trial
10 Aug 2017 ARCA biopharma Announces GENETIC-AF Data and Safety Monitoring Board Recommendation to Complete Phase 2B GENETIC-AF Clinical Trial Based on Efficacy and Safety Data in Phase 2B Interim Analysis
10 Aug 2017 Can-Fite Completes Patient Enrolment for its Phase II Study of Namodenoson in the Treatment of Liver Cancer
10 Aug 2017 Bonti Announces Topline Results of EB-001 Phase 2A Clinical Study in Glabellar Lines
10 Aug 2017 Allegro Ophthalmics Announces Positive Topline Results from DEL MAR Phase 2b Stage 2 Trial Evaluating LuminateĀ® in Patients with Diabetic Macular Edema
10 Aug 2017 REGENXBIO Announces IND Active for Phase I Trial of RGX-111 to Treat Mucopolysaccharidosis Type I
10 Aug 2017 Roivant Sciences Raises $1.1 Billion in Equity Investment Led by SoftBank Vision Fund
10 Aug 2017 Cempra and Melinta Announce Merger to Form Leading, Vertically Integrated Commercial-Stage Anti-Infectives Company
10 Aug 2017 Klaria signs exclusive development, license and supply agreement with Purdue Pharma (Canada) for acute treatment of opioid overdose (KL-00514)
10 Aug 2017 Heron Therapeutics Announces Initiation of Phase 3 Program for HTX-011 in Postoperative Pain Following Successful End-of-Phase 2 Meeting with FDA
10 Aug 2017 Lipocine Resubmits NDA for Its Oral Testosterone Product Candidate, LPCN 1021, for Treatment of Hypogonadism
09 Aug 2017 Theravance Biopharma Reports Encouraging Data from First Cohort of Patients in Phase 1b Clinical Trial of TD-1473 in Ulcerative Colitis
09 Aug 2017 Esperion Announces Positive Top-Line Results From Phase 2 Study of Bempedoic Acid / Ezetimibe Combination Plus Atorvastatin

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top